Given drug shortages and staffing challenges, adopting ready-to-use products can reduce compounding risks and simplify distribution. VANCO READY® Vancomycin Injection, USP, is a premix, room temperature stable formulation. VANCO READY® has a boxed warning and is not for use during first and second trimester of pregnancy.
Cody Parsons will discuss the operationalization of RTU vancomycin, outlining important patient considerations, storage requirements, EHR adaptation, and workflow simplifications. For full prescribing and safety information please visit
www.vancoready.com.
